FolioLanternBeta
IONSIonis Pharmaceuticals Inc

Joseph Wender

Director at Ionis Pharmaceuticals Inc, as of Dec 3, 2025Sold $4.3M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
52K
shares held after the latest filing, Ionis Pharmaceuticals Inc
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
56K
shares sold, past 12 months
3
days with sales
$2.3M
largest single day, Dec 1, 2025
1
company filed for

Share of stake sold at Ionis Pharmaceuticals Inc is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $2.1M under a disclosed planOctNovDec 2025: $2.3M under a disclosed plan$2.3MDecJanFebMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Ionis Pharmaceuticals Inc (IONS)DirectorJan 15, 2004Dec 3, 2025

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.